Carroll Patrick Harrison 4

What Happened

• Carroll Patrick Harrison, Chief Medical Officer of Hims & Hers Health, Inc. (HIMS), had derivative instruments converted into common stock: 3,656 shares on 2026-06-11 and 435 shares on 2026-06-15, for a total of 4,091 shares. The Form 4 reports these as "Exercise or conversion of derivative" (transaction code M) with $0 proceeds, indicating conversion/settlement of RSUs/derivatives rather than a cash sale.

Key Details

• Transaction dates and amounts: 2026-06-11 — 3,656 shares (conversion); 2026-06-15 — 435 shares (conversion). Both reported at $0 proceeds (derivative conversion).
• These RSUs represent a contingent right to receive one share per RSU and were subject to vesting conditions (see footnotes). The 435-share conversion corresponds to RSUs issued in lieu of a $10,000 director retainer (grant price $22.98).
• Footnotes of note: F1/F4 — RSUs convert to one share each and vest by the earlier of the 2026 annual meeting or June 15, 2026; F2 — reporting person acquired 1,440 shares on May 20, 2026 under the ESPP; F3 — 435 RSUs were issued under the Director Compensation Policy in lieu of cash fees.
• Filing timeliness: The Form 4 was filed on 2026-06-15 for transactions on 2026-06-11 and 2026-06-15; the filing shows no indication of lateness.

Context

• These entries reflect conversion/vesting of restricted stock units into common shares, not an open‑market purchase or sale. Conversions with $0 proceeds are routine corporate/compensation events (including vesting and settlement for taxes) and do not by themselves indicate the insider bought or sold stock for investment purposes.